REGENERON PHARMACEUTICALS

Ticker: REGN CUSIP: 75886F107 Class: COM

HARVEY CAPITAL MANAGEMENT INC's Holding History (CIK: 0001119032)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 10,198 Value ($000) $7,872 Avg Close $678.68 Range $540.32 - $792.77

Q3 2025

Shares 11,402 Value ($000) $6,411 Avg Close $564.28 Range $519.56 - $609.69

Q2 2025

Shares 11,742 Value ($000) $6,281 Avg Close $556.12 Range $475.17 - $638.52

Q1 2025

Shares 13,092 Value ($000) $8,303 Avg Close $684.44 Range $615.89 - $745.12

Q4 2024

Shares 13,064 Value ($000) $9,306 Avg Close $834.60 Range $689.18 - $1055.74

Q3 2024

Shares 12,822 Value ($000) $13,479 Avg Close $1106.73 Range $1002.85 - $1204.52

Q2 2024

Shares 12,857 Value ($000) $13,513 Avg Close $964.05 Range $870.40 - $1075.21

Q1 2024

Shares 12,927 Value ($000) $12,442 Avg Close $945.64 Range $866.58 - $992.82

Q4 2023

Shares 13,004 Value ($000) $11,421 Avg Close $818.96 Range $764.95 - $894.90

Q3 2023

Shares 13,131 Value ($000) $10,806 Avg Close $781.58 Range $684.72 - $842.83

Q2 2023

Shares 13,161 Value ($000) $9,457 Avg Close $766.75 Range $681.03 - $832.93

Q1 2023

Shares 12,580 Value ($000) $10,337 Avg Close $750.05 Range $664.32 - $830.39

Q4 2022

Shares 12,720 Value ($000) $9,177 Avg Close $733.79 Range $690.81 - $774.70

Q3 2022

Shares 12,730 Value ($000) $8,769 Avg Close $625.92 Range $560.71 - $750.51

Q2 2022

Shares 15,810 Value ($000) $9,345 Avg Close $646.43 Range $535.04 - $743.30

Q1 2022

Shares 16,893 Value ($000) $11,798 Avg Close $629.16 Range $589.59 - $706.29

Q4 2021

Shares 16,795 Value ($000) $10,606 Avg Close $611.44 Range $536.21 - $670.14

Q3 2021

Shares 15,762 Value ($000) $9,538 Avg Close $617.39 Range $551.89 - $682.83

Q2 2021

Shares 17,162 Value ($000) $9,585 Avg Close $503.83 Range $466.78 - $566.85

Q1 2021

Shares 11,057 Value ($000) $5,231 Avg Close $484.19 Range $438.57 - $555.83

Q3 2020

Shares 400 Value ($000) $223 Avg Close $602.99 Range $537.02 - $660.97

Q2 2020

Shares 450 Value ($000) $280 Avg Close $564.49 Range $473.82 - $642.77

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	10,198	$7,872	$678.68	$540.32 - $792.77
Q3 2025	11,402	$6,411	$564.28	$519.56 - $609.69
Q2 2025	11,742	$6,281	$556.12	$475.17 - $638.52
Q1 2025	13,092	$8,303	$684.44	$615.89 - $745.12
Q4 2024	13,064	$9,306	$834.60	$689.18 - $1055.74
Q3 2024	12,822	$13,479	$1106.73	$1002.85 - $1204.52
Q2 2024	12,857	$13,513	$964.05	$870.40 - $1075.21
Q1 2024	12,927	$12,442	$945.64	$866.58 - $992.82
Q4 2023	13,004	$11,421	$818.96	$764.95 - $894.90
Q3 2023	13,131	$10,806	$781.58	$684.72 - $842.83
Q2 2023	13,161	$9,457	$766.75	$681.03 - $832.93
Q1 2023	12,580	$10,337	$750.05	$664.32 - $830.39
Q4 2022	12,720	$9,177	$733.79	$690.81 - $774.70
Q3 2022	12,730	$8,769	$625.92	$560.71 - $750.51
Q2 2022	15,810	$9,345	$646.43	$535.04 - $743.30
Q1 2022	16,893	$11,798	$629.16	$589.59 - $706.29
Q4 2021	16,795	$10,606	$611.44	$536.21 - $670.14
Q3 2021	15,762	$9,538	$617.39	$551.89 - $682.83
Q2 2021	17,162	$9,585	$503.83	$466.78 - $566.85
Q1 2021	11,057	$5,231	$484.19	$438.57 - $555.83
Q3 2020	400	$223	$602.99	$537.02 - $660.97
Q2 2020	450	$280	$564.49	$473.82 - $642.77